Shares in Annies Inc. (NYSE:BNNY) have plunged on news that the Company has identified material weaknesses in its internal control over financial reporting and on news that the Company’s independent auditor, PricewaterhouseCoopers LLP, is resigning. Annies Inc. (NYSE:BNNY) net profit margin is 7.40% and weekly performance is -13.19%. On last trading day company shares ended up $30.07. Analysts mean target price for the company is $36.00. Annies Inc. (NYSE:BNNY) distance from 50-day simple moving average (SMA50) is -14.19%.
On May 15, 2014, Jacques Kerrest notified MagneGas Corporation (NASDAQ:MNGA) that he would resign from his position as a member of the board of directors of the Company, effective immediately. MagneGas Corporation (NASDAQ:MNGA) shares fell -6.17% in last trading session and ended the day on $1.52. MNGA gross Margin is 50.00% and its return on assets is -83.30%.MagneGas Corporation (NASDAQ:MNGA) quarterly performance is 92.41%.
Shares of Retrophin Inc. (NASDAQ:RTRX) , a predominantly clinical-stage biopharmaceutical company focused on the development of therapies to treat rare disease, tumbled as much as 12% on Wednesday following a Form 4 filing with the Securities and Exchange Commission that showed CEO Martin Shkreli sold shares of common stock. Retrophin Inc. (NASDAQ:RTRX) shares moved down -11.91% in last trading session and was closed at $11.76, while trading in range of $11.51 – $13.24. Retrophin Inc. (NASDAQ:RTRX) year to date (YTD) performance is 68.00%.
Prana Biotechnology (NASDAQ: PRAN) is pleased to announce on 14 may Professor Ira Shoulson will join the Company’s Board of Directors as a Non-Executive Director. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) ended the last trading day at $1.71. Company weekly volatility is calculated as 7.38% and price to cash ratio as 4.45.Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) showed a negative weekly performance of -18.57%.
Transcept Pharmaceuticals (NASDAQ:TSPT), the stock is falling as result of company declaring ex-dividends Wednesday. Transcept Pharmaceuticals Inc. (NASDAQ:TSPT) weekly performance is -35.22%. On last trading day company shares ended up $2.06. Analysts mean target price for the company is $4.10. Transcept Pharmaceuticals Inc. (NASDAQ:TSPT) distance from 50-day simple moving average (SMA50) is -31.90%.